Comparison of aripiprazole augmentation versus bupropion combination for patient with major depressive disorder

被引：1
|
作者：
Lee, K. [1 ]
Lee, J. B. [2 ]
Park, Y. W. [3 ]
Lee, J. H. [4 ]
Lee, S. J. [5 ]
Koo, B. H. [5 ]
Sung, H. M. [6 ]
Cheon, E. J. [5 ]
机构：
[1] Dongguk Univ Hosp, Psychiat, Gyeongjy, South Korea
[2] Yeungnam Univ Hosp, Psychiat, Daegu, South Korea
[3] Fatima Hosp, Psychiat, Daegu, South Korea
[4] Catholic Univ Daegu Hosp, Psychiat, Daegu, South Korea
[5] Kyungpook Univ Hosp, Psychiat, Daegu, South Korea
[6] Cha Univ Hosp, Psychiat, Gumi, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70724-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.003
引用
收藏
页码：S452 / S453
页数：2
相关论文
共 50 条
  • [41] Aripiprazole as adjunctive therapy in patients with major depressive disorder
    Graber, Mark A.
    Dachs, Robert
    Darby-Stewart, Andrea
    AMERICAN FAMILY PHYSICIAN, 2008, 78 (03) : 308 - +
  • [42] Aripiprazole augmentation of SSRIs and SNRIs for the treatment of partial and non-responding patients with major depressive disorder
    Nemeroff, CB
    Simon, JS
    Forbes, A
    Carson, WH
    McQuade, R
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S209 - S209
  • [43] Antidepressants augmented with aripiprazole in the treatment of major depressive disorder
    Bise, S.
    Sulejmanpasic, G.
    Begic, D.
    Ahmic, M.
    EUROPEAN PSYCHIATRY, 2017, 41 : S141 - S141
  • [44] Aripiprazole Augmentation for a Patient With Partial Remission of Panic Disorder
    Harada, Tsuyoto
    Yamada, Kazuo
    Sakamoto, Kaoru
    Ishigooka, Jun
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (03) : 301 - 302
  • [45] Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded,prospective study
    Han, Changsu
    Wang, Sheng-Min
    Kwak, Kyung-Phil
    Won, Wang-Yeon
    Lee, HwaYoung
    Chang, Chia Ming
    Tang, Tze Chun
    Pae, Chi-Un
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 66-67 : 84 - 94
  • [46] Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder
    Eller, T.
    Vasar, V.
    Shlik, J.
    Maron, E.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (07) : 854 - 858
  • [47] Bupropion-Related Sexual Dysfunction and Possible Management in a Fresh Patient With Major Depressive Disorder
    Lai, Chien-Han
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2014, 26 (02) : E18 - E19
  • [48] Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive Disorder
    Park, Young-Min
    Lee, Heon-Jeong
    Kang, Seung-Gul
    Cho, Jae-Hyuck
    Kim, Leen
    PSYCHIATRY INVESTIGATION, 2009, 6 (04) : 313 - 315
  • [49] Is augmentation with folate effective for major depressive disorder?
    Trincado, Javier
    Caneo, Constanza
    MEDWAVE, 2018, 18 (01):
  • [50] Augmentation of Dopaminergic Agents for Major Depressive Disorder
    Pae, Chi-Un
    Patkar, Ashwin A.
    Masand, Prakash S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (03) : 432 - 433
12345